Final answer: Ghrelin can suppress insulin secretion in humans,but Is It Clinically Relevant?

QIAN Rong-li
2012-01-01
Abstract:Ghrelin is a 28-amino acid peptide initially isolated from rat and human stomachs as an endogenous ligand for the growth hormone secretagogue receptor type 1a(GHS-R1a)and was discovered in 1999.Ghrelin was known to increase growth hormone release from the pituitary gland by binding to GHS-R1a,which had a role in food intake and body adiposity,and regulated cell proliferation and survival,apoptosis,inflammation,angiogenesis,development and reproduction as well as metabolism.Recently,it has been of great research interest whether ghrelin also has a role inβ-cell function or not.This research area is particularly important given its potential to lead to the development of novel strategies to increase insulin secretion for the treatment of type 2diabetes.Here we translated the essentials of"Final answer: Ghrelin can suppress insulin secretion in humans,but is it clinically relevant?(Diabetes,2010,59:27262728)"in the following article.
What problem does this paper attempt to address?